Sage Therapeutics Inc.

NAS: SAGE

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Sage Therapeutics Inc.

After Hours

SAGE

/zigman2/quotes/200179567/composite

69.00

Change

-1.65 -2.34%

Volume

Volume 988

Mar 4, 2021, 7:10 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200179567/composite

Previous close

$ 76.17

$ 70.65

Change

-5.52 -7.25%

Day low

Day high

$69.32

$75.13

Open: 75.13

52 week low

52 week high

$25.01

$98.39

Market cap

$4.45B

Average volume

496,064

P/E ratio

6.37

Rev. per Employee

$3.74M

EPS

11.09

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:

Indexes

Dow(INDU) INDU
Nasdaq (COMP) COMP
S&P 500 (SPX) SPX
Global Dow (GDOW) GDOW

/news/latest/company/us/sage

MarketWatch News on SAGE

Sage Therapeutics downgraded to neutral from buy at Mizuho

7:51 a.m. Feb. 26, 2021

- Tomi Kilgore
Biogen’s Alzheimer’s Drug Faces a Big Test

9:57 a.m. Feb. 11, 2021

- Barron's Online
Sage Therapeutics downgraded to market perform at BMO Capital

8:58 a.m. Jan. 22, 2021

- Tomi Kilgore
Tech stocks won’t crash according to this fund manager, dubbed the English Warren Buffett

8:35 a.m. Jan. 22, 2021

- Rupert Steiner
Stocks Close Higher on Stimulus Hopes, Manufacturing Data

6:03 p.m. Dec. 1, 2020

- Barron's Online
Zoom Stock Falls as News From China Lifts the Dow.

8:57 a.m. Dec. 1, 2020

- Barron's Online
Sage Therapeutics downgraded to market perform from outperform at Raymond James

8:20 a.m. Dec. 1, 2020

- Tomi Kilgore
S&P 500, Nasdaq book record closes on Black Friday

4:11 p.m. Nov. 27, 2020

- Mark DeCambre
S&P 500 and Nasdaq Close at Records as Tech Stocks Outperform

1:32 p.m. Nov. 27, 2020

- Barron's Online
Sage Gets $3 Billion Endorsement of Its Depression Drugs From Biogen

11:26 a.m. Nov. 27, 2020

- Barron's Online
UPDATE: Sage Therapeutics to receive $1.525 billion in cash in deal with Biogen to jointly develop depression, tremor therapies

8:18 a.m. Nov. 27, 2020

- Ciara Linnane
Sage Soars, AstraZeneca Slips and the Dow Gets a Black Friday Bump

8:20 a.m. Nov. 27, 2020

- Barron's Online
Sage Therapeutics shares soar 10% premarket after resuming trade following halt

8:03 a.m. Nov. 27, 2020

- Ciara Linnane
Sage Therapeutics shares halted premarket for the news

7:32 a.m. Nov. 27, 2020

- Ciara Linnane
Biogen and Sage Therapeutics to jointly develop therapies for depression and movement disorders

7:31 a.m. Nov. 27, 2020

- Ciara Linnane
Sage Therapeutics to receive $1.525 bln in cash from Biogen as part of deal

7:32 a.m. Nov. 27, 2020

- Ciara Linnane
Sage Therapeutics stock price target raised to $77 from $53 at Mizuho

6:34 a.m. Nov. 6, 2020

- Tomi Kilgore
Sage Therapeutics upgraded to outperform from neutral at Wedbush

6:08 a.m. Sept. 11, 2020

- Tomi Kilgore
Mylan Is Eager to Launch Rival Version of Biogen’s Biggest-Selling Drug

10:01 a.m. June 19, 2020

- Barron's Online
Sage Therapeutics downgraded to neutral from outperform at Wedbush

6:35 a.m. May 8, 2020

- Tomi Kilgore
Loading more headlines...